Compumedics (ASX:CMP) Receipts from Customers: A$53.95 Mil (TTM As of Dec. 2025)


ASX:CMP Compumedics Ltd ASX:CMP
62 GF Score
Price A$0.22
GF Value A$0.32
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Compumedics Receipts from Customers?

Compumedics ASX:CMP -13.73% 62 Receipts from Customers is A$53.95 Mil as of Dec. 2025. GuruFocus rates ASX:CMP with a GF Score™ of 62/100 and a GF Value™ of A$0.32 (Possible Value Trap). The stock has 4 warning signs investors should review.

Compumedics's Receipts from Customers for the six months ended in Dec. 2025 was A$31.75 Mil.

Compumedics's Receipts from Customers for the trailing twelve months (TTM) ended in Dec. 2025 was A$53.95 Mil.

Compumedics Receipts from Customers Historical Data

* Premium members only.

The historical data trend for Compumedics's Receipts from Customers can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Compumedics Receipts from Customers Chart

Compumedics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Receipts from Customers
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.49 36.54 45.41 52.94 45.52

Compumedics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Receipts from Customers Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.21 24.73 23.32 22.20 31.75
ASX:CMP
62GF Score
Compumedics Ltd ASX:CMP
Receipts from Customers is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compumedics Receipts from Customers Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Receipts from Customers represents payment received from customers in the direct cash flow method.

Receipts from Customers for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$53.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Receipts from Customers of A$53.95 Mil mean?
Compumedics (ASX:CMP) has a Receipts from Customers of A$53.95 Mil as of Dec. 2025. Receipts from Customers represents payment received from customers in the direct cash flow method. View historical data for Compumedics and its competitors.
Is Compumedics' Receipts from Customers too high?
Compumedics' current Receipts from Customers is A$53.95 Mil. Overall, Compumedics has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Compumedics' Receipts from Customers compare to ABT and SYK?
Compumedics' Receipts from Customers of A$53.95 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receipts from Customers for a Medical Devices & Instruments company?
A good Receipts from Customers depends on the Medical Devices & Instruments industry context. However, Receipts from Customers should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receipts from Customers mean?
A high Receipts from Customers can signal that a stock is expensive relative to its fundamentals. Receipts from Customers represents payment received from customers in the direct cash flow method. View historical data for Compumedics and its competitors. Compumedics's current Receipts from Customers is A$53.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compumedics stock overvalued right now?
Based on GuruFocus' analysis, Compumedics (ASX:CMP) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.32, compared to a current price of A$0.22 — trading 31.3% below its estimated fair value. The current Receipts from Customers is A$53.95 Mil. Compumedics' overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receipts from Customers calculated?
Receipts from Customers is calculated from a company's financial statements. For Compumedics (ASX:CMP), the current Receipts from Customers is A$53.95 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Compumedics (ASX:CMP) Overvalued in 2026?

Based on GuruFocus' analysis, Compumedics stock appears to be undervalued. The current stock price of A$0.22 is trading 31.3% below its estimated GF Value™ of A$0.32. GuruFocus considers Compumedics to be Possible Value Trap.

Key valuation signals for ASX:CMP:

  • Receipts from Customers: A$53.95 Mil
  • GF Value™: A$0.32 vs. price of A$0.22 (31.3% below fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the ASX:CMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Compumedics Business Description

Address 30-40 Flockhart Street, Abbotsford, Melbourne, VIC, AUS, 3067
Compumedics Ltd is a medical device company. It is engaged in the development, manufacturing, and commercialization of diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
62GF Score

Get the complete analysis for ASX:CMP

Receipts from Customers is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.22
Price
A$0.32
GF Value